Zepbound is FDA-approved for chronic weight management in adults with a BMI of 30+ (or 27+ with a weight-related condition)
Ma MZ, Chen G, Wang P, Lu WH, Zhu CF, Song M, et al
Traveling with Retatrutide requires advance planning for temperature maintenance
Benefits of Injectable Administration Systemic Effects: Provides whole-body benefits, including potential hair growth stimulation and systemic tissue repair
Dulaglutide has no role in obesity-first prescribing under current guidelines
One employer in Nomi Health's data found GLP-1 users had 40% lower medical costs despite 2.5x higher pharmacy spend, with fewer prescriptions for comorbidities and better health markers overall